Sanofi Consumer Healthcare India Ltd Share Price Live
Live Sanofi Consumer Healthcare India Share Price Chart
Sanofi Consumer Healthcare India Performance
Days Range
| Previous Close | ₹4,737.50 |
|---|---|
| Open | ₹4,725.7 |
| Volume | 2,129 |
| Day's Range | ₹4,646.40 - ₹4,732.10 |
|---|---|
| 52W Range | ₹4,537.45 - ₹5,894.50 |
| Market Cap | ₹10,938.28 Cr |
Sanofi Consumer Healthcare India Fundamentals
| ROCE(TTM) | 92.58 |
|---|---|
| P/E Ratio (TTM) | 50.2 |
| P/B Ratio | 42.56 |
| Industry P/E | 40.32 |
| Debt to Equity | 0.11 |
| ROE | 77.82 |
| EPS (TTM) | 93.3 |
| Dividend Yield | 1.16 |
| Book Value | 111.60 |
| Face Value | 10 |
| ROCE(TTM) | 92.58 |
|---|---|
| P/E Ratio (TTM) | 50.2 |
| P/B Ratio | 42.56 |
| Industry P/E | 40.32 |
| Debt to Equity | 0.11 |
| ROE | 77.82 |
|---|---|
| EPS (TTM) | 93.3 |
| Dividend Yield | 1.16 |
| Book Value | 111.60 |
| Face Value | 10 |
Sanofi Consumer Healthcare India Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 170.70 | 172.60 | 220.90 | 233.90 |
| Expenses | 109.60 | 110.60 | 153.70 | 152.20 |
| Profit before tax | 62.80 | 66.80 | 78.90 | 84.10 |
| Operating Profit | 44.30 | 50.00 | 60.70 | 62.90 |
| Net Profit | 44.30 | 50.00 | 60.70 | 62.90 |
| ESP in Rs | 20.51 | 21.69 | 23.49 | 27.31 |
Sanofi Consumer Healthcare India Shareholding Pattern
| Held by | Oct 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 60.4% | 60.4% | 60.4% | 71.27% | 71.27% |
| Flls | 4.87% | 4.42% | 4.53% | 3.24% | 2.94% |
| Dlls | 24.51% | 25.35% | 25.48% | 16.89% | 17.21% |
| Public | 10.22% | 9.84% | 9.59% | 8.59% | 8.58% |
About Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity. The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company.
Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger.
The demerger was strategically undertaken to facilitate independent and focused management for both businesses, enhance operational efficiency, provide greater transparency for stakeholders, and unlock shareholder value. This separation empowered each entity to implement tailored strategies aligned with its respective industry dynamics, ensuring greater agility and long-term growth.
The effective date of the Scheme was June 1, 2023. As per the Scheme, eligible shareholders of SIL received one fully paid-up equity share of the Company for every share they held in SIL on June 13, 2024.
Parent Organisation
MNC Asc-Hoechst
Managing Director
None
Founded
2023
NSE Symbol
SANOFICONR
Top Mutual Funds Invested in Sanofi Consumer Healthcare India Share
Top Mutual Funds Invested in Sanofi Consumer Healthcare India Share
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,831.1 20.80 (1.15%) | ₹4,34,159.66 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,471.0 -19.50 (-0.30%) | ₹1,72,287.78 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,722.0 -8.40 (-0.23%) | ₹1,26,434.15 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,530.9 5.70 (0.37%) | ₹1,23,148.76 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,257.1 7.80 (0.62%) | ₹1,04,369.38 | 1,020.0 - 1,405.9![]() |
| Lupin Ltd | 2,085.1 13.70 (0.66%) | ₹94,659.39 | 1,795.2 - 2,402.9![]() |
Popular stocks
Sanofi Consumer Healthcare India Ltd FAQs
What is the share price of Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares?
Sanofi Consumer Healthcare India Ltd (SANOFICONR) share price as of November 28, 2025, on NSE is Rs 4659.7 (NSE) and Rs 4659.7 (BSE) on BSE.
Can I buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) from Angel One?
Yes, You can buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares by opening a Demat account with Angel One.
How do I buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) from Angel One?
Sanofi Consumer Healthcare India Ltd (SANOFICONR) share can be bought through the following modes:
1. Direct investment: You can buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares.
1. Direct investment: You can buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares.




